NPPB and hydrops fetalis: Other studies have found that CRP in combination with other biomarkers of inflammation and neurohumoral activation, such as ST-2, Growth differentiation factor-15, and NT-pro BNP may be useful in prognostication in HF, although these studies had relatively few patients with HFpEF[30, 31].